Literature DB >> 21519327

Functional characterization of osteosarcoma cell lines provides representative models to study the human disease.

Alexander B Mohseny1, Isidro Machado, Yongping Cai, Karl-Ludwig Schaefer, Massimo Serra, Pancras C W Hogendoorn, Antonio Llombart-Bosch, Anne-Marie Cleton-Jansen.   

Abstract

Cancer cell lines represent in vitro models for studying malignancies, general cell biology, drug discovery and more. Whether they can be considered as exact representative models of the parental tumors remains uncertain given the acquisition of additional ex vivo changes of the cells and the lack of tissue architecture and stroma. Previously, within the EuroBoNeT consortium, we characterized a collection of bone sarcoma cell lines on genomic and proteomic level. Here, we address the phenotypical and functional characterization of the unique set of osteosarcoma cell lines (n=19) in vitro and in vivo. For functional analysis of differentiation capacity, cells were stimulated towards osteoblasts, adipocytes and chondrocytes. Furthermore, all cell lines were injected subcutaneously and intramuscularly into nude mice to assay their in vivo tumor formation capacity as well as for phenotypical analysis of the tumors. All formed tumors were further characterized histologically and immunohistochemically. Out of 19 cell lines, 17 (89%) showed adipogenic differentiation, 13/19 (68%) could differentiate towards osteoblasts and in 6/19 (32%) cell lines chondrogenic differentiation was evident. About half of the cell lines (8/19, 42%) produced tumors in vivo after subcutaneous and intramuscular injections. Several cell lines showed invasion into adjacent tissues and one tumor developed several lung metastases. The use of cell lines, especially in cancer research, is of paramount importance. Here, we identify comprehensively characterized osteosarcoma cell lines, which robustly represent clinical osteosarcoma providing researchers useful in vitro and in vivo models to study the genetics and functional characteristics of this highly malignant neoplasm.

Entities:  

Mesh:

Year:  2011        PMID: 21519327     DOI: 10.1038/labinvest.2011.72

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  71 in total

1.  Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.

Authors:  Yong Zhao; Mei-Juan Tu; Yi-Feng Yu; Wei-Peng Wang; Qiu-Xia Chen; Jing-Xin Qiu; Ai-Xi Yu; Ai-Ming Yu
Journal:  Biochem Pharmacol       Date:  2015-10-27       Impact factor: 5.858

2.  The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.

Authors:  Ritu Shekhar; Priyanka Priyanka; Praveen Kumar; Tanushree Ghosh; Md Muntaz Khan; Perumal Nagarajan; Sandeep Saxena
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

3.  FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53.

Authors:  Hanjun Li; Xiuguo Han; Shengbing Yang; Yongjie Wang; Yang Dong; Tingting Tang
Journal:  Oncogene       Date:  2021-03-14       Impact factor: 9.867

4.  The depalmitoylase APT1 directs the asymmetric partitioning of Notch and Wnt signaling during cell division.

Authors:  Ewa Stypulkowski; Irfan A Asangani; Eric S Witze
Journal:  Sci Signal       Date:  2018-01-02       Impact factor: 8.192

5.  PTEN loss activates a functional AKT/CXCR4 signaling axis to potentiate tumor growth and lung metastasis in human osteosarcoma cells.

Authors:  Yongming Xi; Zonghua Qi; Jinfeng Ma; Yan Chen
Journal:  Clin Exp Metastasis       Date:  2019-09-30       Impact factor: 5.150

6.  Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells.

Authors:  Yuewen Chang; Yongfang Zhao; Hongsheng Zhan; Xiaoen Wei; Tianjin Liu; Bo Zheng
Journal:  Tumour Biol       Date:  2013-09-05

Review 7.  Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?

Authors:  Jennifer A Byrne; Sarah Frost; Yuyan Chen; Robert K Bright
Journal:  Tumour Biol       Date:  2014-05-06

8.  Neurexin Superfamily Cell Membrane Receptor Contactin-Associated Protein Like-4 (Cntnap4) Is Involved in Neural EGFL-Like 1 (Nell-1)-Responsive Osteogenesis.

Authors:  Chenshuang Li; Zhong Zheng; Pin Ha; Xiaoyan Chen; Wenlu Jiang; Shan Sun; Feng Chen; Greg Asatrian; Emily A Berthiaume; Jong Kil Kim; Eric C Chen; Shen Pang; Xinli Zhang; Kang Ting; Chia Soo
Journal:  J Bone Miner Res       Date:  2018-06-29       Impact factor: 6.741

9.  Tissue factor associates with survival and regulates tumour progression in osteosarcoma.

Authors:  Chris Tieken; Michiel C Verboom; Wolfram Ruf; Hans Gelderblom; Judith V M G Bovée; Pieter H Reitsma; Anne-Marie Cleton-Jansen; Henri H Versteeg
Journal:  Thromb Haemost       Date:  2016-01-14       Impact factor: 5.249

10.  Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis.

Authors:  Maria Angeles Lillo Osuna; Jesus Garcia-Lopez; Ikbale El Ayachi; Iram Fatima; Aysha B Khalid; Jerusha Kumpati; Alexandria V Slayden; Tiffany N Seagroves; Gustavo A Miranda-Carboni; Susan A Krum
Journal:  Cancer Res       Date:  2018-12-28       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.